Reduce the global burden of RSV infection
RSV Awareness Online Tool
The aim of the RSV Awareness online tool is to track global public awareness of Respiratory Syncytial Virus (RSV) by utilizing online search volumes.
RSV Research
Patient Network
RSVVW’24 Conference
Registration is open!
Submit your abstract!
Scientific program!
RSV Awareness Week 2023,
was on 6 – 10 November!
For the fifth consecutive year, we are gearing up for an essential event – RSV Awareness Week 2023. Our mission remains to disseminate knowledge about RSV, ensuring that young parents, parents-to-be, and older adults are well-informed about this virus. You can make a difference during RSV Awareness Week by joining us on our journey to amplify RSV awareness. Follow the social media channels of our RSV Patient Network and “Share to be RSV Aware!”
News updates
Upcoming RSV Webinar: “RSV Travels by Airplane”
During the 14th webinar of ReSViNET’s RSV Webinar Series, Prof Philippe Lemey, will share his insights on RSV Travels by Airplane. He is the senior editor of the second edition of the Phylogenetic Handbook and a two-time ERC grant awardee. Philippe is now a full Professor at the Rega Institute, KU Leuven, where he studies the evolutionary processes that shape viral genetic diversity, spanning large-scale epidemic processes as well as small-scale transmission histories and within-host evolutionary processes.
Paper of the Month: September 2023
The search for a connection between RSV and asthma
Authors: Sandy Ong
The consequences of respiratory syncytial virus infection sometimes linger for years — and scientists are trying to work out whether there’s a causal link.
Rachael Thomas is sharing her personal story about her son Alexander. She says she speaks to many parents whose babies have survived an RSV infection but continue to experience long-term effects, such as asthma. “The children just seem more susceptible.”
RSV Dashboard
We are proud to announce we have developed the first-ever global RSV surveillance dashboard and it is now live!
ReSViNET Foundation, in collaboration with AstraZeneca, is supporting healthcare decisions by providing transparency and accessibility to shared global RSV surveillance data. The dashboard will help simplify tracking changes in RSV seasonality globally. This will include at least 20 countries that are representative of different geographic regions from both hemispheres.
Connecting research and society
The ReSViNET Foundation is the first and leading global non-profit organisation fully committed to reducing the global burden of the Respiratory Syncytial Virus (RSV).
We collaborate with researchers, the health sector, governments, international statutory bodies, non-profit organisations and the wider civil society in an effort to coordinate actions and raise awareness about RSV infection and to tackle the challenge of RSV infection prevention and treatment.
A global health challenge
Every year, Respiratory Syncytial Virus (RSV) affects more than 33 million children under 5 years worldwide. It is one of our most significant global healthcare challenges, not only in infants, but also in older adults. ReSViNET is the first official RSV foundation and aims to provide a platform for global collaborations to raise awareness about RSV infection and stimulate the development of RSV prevention and treatment.